Physician profile
Edwin George Avery
NPI 1639157241
$194,005.73
in general payments reported to CMS, 2019-2025
12 companies · $99.72 in 2025
The $99.72 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $40K · 2021: $25K · 2022: $26K · 2023: $10K · 2024: $5,322 · 2025: $99.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,625 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,630 · Travel and Lodging: $1,061 · Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,625.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,630.00 |
| Travel and Lodging | $1,061.05 |
| Food and Beverage | $253.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $72,361.05 | 2019-2024 | Cleviprex |
| Medtronic, INC. | $37,174.66 | 2021-2025 | Invos, Bis |
| Medtronic Vascular, INC. | $34,696.97 | 2019-2020 | |
| Covidien Lp | $33,472.98 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $14,422.39 | 2019-2022 | |
| Chugai Pharmaceutical Co., Ltd. | $1,040.00 | 2019 | |
| Ancora Heart, INC. | $536.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $119.31 | 2019 | |
| La Jolla Pharmaceutical Company | $81.05 | 2022 | |
| Livanova USA, INC. | $62.92 | 2020 | |
| Merck Sharp & Dohme LLC | $22.85 | 2023 | Bridion |
| Avanos Medical | $15.55 | 2024 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.